camptothecin has been researched along with Chromosome Instability Syndromes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dalenc, F; Franchet, C; Nicolaï, V; Sarradin, V; Ung, M | 1 |
| Feilchenfeldt, J; Power, DG | 1 |
1 review(s) available for camptothecin and Chromosome Instability Syndromes
| Article | Year |
|---|---|
[Recent therapeutic trends in triple-negative metastatic breast cancers: PARP inhibitors, immunotherapies and antibody-drug conjugates].
Topics: Antibodies, Monoclonal, Humanized; Camptothecin; DNA Repair-Deficiency Disorders; Female; Genes, BRCA1; Genes, BRCA2; Humans; Immunoconjugates; Immunotherapy; Immunotherapy, Adoptive; Poly(ADP-ribose) Polymerase Inhibitors; Treatment Outcome; Triple Negative Breast Neoplasms | 2021 |
1 other study(ies) available for camptothecin and Chromosome Instability Syndromes
| Article | Year |
|---|---|
Irinotecan and mismatch repair deficiency.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Pharmacological; Camptothecin; Carcinoma; Colorectal Neoplasms; DNA Mismatch Repair; DNA Repair-Deficiency Disorders; Drug Resistance, Neoplasm; Humans; Irinotecan; Liver Neoplasms; Postoperative Period; Prognosis | 2010 |